The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| IRMD | +52.8% | +319% | +33.14% | +825% |
| S&P | +12.65% | +91.73% | +13.89% | +240% |
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging (MRI) compatible medical devices. It also provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $21.20M | 15.7% |
| Gross Profit | $16.49M | 16.2% |
| Gross Margin | 77.80% | 0.4% |
| Market Cap | $905.16M | 42.1% |
| Market Cap / Employee | $5.66M | 0.0% |
| Employees | 160 | 8.1% |
| Net Income | $5.58M | 10.4% |
| EBITDA | $7.22M | 20.6% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $56.53M | 9.3% |
| Accounts Receivable | $13.86M | 33.7% |
| Inventory | 11.7 | 4.3% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.00M | -100.0% |
| Short Term Debt | $0.00M | -100.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 20.28% | -0.2% |
| Return On Invested Capital | 15.47% | 1.1% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $5.85M | 10.2% |
| Operating Free Cash Flow | $6.99M | -23.4% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 36.53 | 33.93 | 37.09 | 43.11 | 25.16% |
| Price to Book | 8.35 | 7.68 | 8.44 | 10.05 | 25.64% |
| Price to Sales | 9.62 | 8.96 | 9.89 | 11.37 | 26.12% |
| Price to Tangible Book Value | 8.65 | 7.97 | 8.76 | 10.42 | 25.86% |
| Price to Free Cash Flow TTM | 178.74 | 99.89 | 126.16 | 143.81 | 34.87% |
| Enterprise Value to EBITDA | 108.84 | 110.71 | 102.13 | 118.96 | 20.47% |
| Free Cash Flow Yield | 0.6% | 1.0% | 0.8% | 0.7% | -25.86% |
| Return on Equity | 24.3% | 23.8% | 23.7% | 23.3% | -1.15% |
| Total Debt | $0.15M | $0.06M | $0.00M | $0.00M | - |
No podcast episodes available.
IRMD earnings call for the period ending March 31, 2020.
IRMD earnings call for the period ending December 31, 2019.
IRMD earnings call for the period ending September 30, 2019.
IRMD earnings call for the period ending June 30, 2019.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
